ABSTRACT. The anesthetic sparring and cardiovascular effects produced by midazolam 0.8 mg/ml-ketamine 40 mg/ml-medetomidine 0.05 mg/ml (0.025 ml/kg/hr) drug infusion during sevoflurane in oxygen (MKM-OS) anesthesia was determined in healthy horses. The anesthetic sparring effects of MKM-OS were assessed in 6 healthy thoroughbred horses in which the right carotid artery was surgically relocated to a subcutaneous position. All horses were intubated and ventilated with oxygen using intermittent positive pressure ventilation (IPPV). The end-tidal concentration of sevoflurane (ET SEV ) required to maintain surgical anesthesia was approximately 1.7%. Heart rate and mean arterial blood pressure averaged 23-41 beats/min and 70-112 mmHg, respectively. All horses stood between 23-44 min after the cessation of all anesthetic drugs. The cardiovascular effects of MKM-OS anesthesia were evaluated in 5 healthy thoroughbred horses ventilated using IPPV. Anesthesia was maintained for 4 hr at an ET SEV of 1.7%. Each horse was studied during left lateral (LR) and dorsal recumbency (DR) with a minimum interval between evaluations of 1 month. Cardiac output and cardiac index were maintained between 70-80% of baseline values during LR and 65-70% of baseline values during DR. Stroke volume was maintained between 75-85% of baseline values during LR and 60-70% of baseline values during DR. Systemic vascular resistance was not different from baseline values regardless of position. MKM-OS anesthesia may be useful for prolonged equine surgery because of its minimal cardiovascular depression in both of lateral and dorsal recumbency.
Morbidity and mortality in clinical equine anesthesia is considerably greater than other domestic species and this is usually caused by hypotension and hypoventilation during anesthesia [29] . All volatile anesthetic agents cause dosedependent cardiopulmonary depression, hypoventilation and hypotension at inspired concentrations required to provide a surgical plane of anesthesia [22] . Furthermore, horses positioned in dorsal recumbency fall into severer cardiovascular depression than those positioned in lateral recumbency [9, 19] . Therefore, assisted and controlled ventilation and administration of inotropic agents may be required during inhalation anesthesia in horses [22] . Intermittent positive-pressure ventilation (IPPV) prevents hypoventilation during inhalation anesthesia in horses, but may lead to further cardiac depression. In general, hypotension is treated with the infusion of dobutamine during inhalation anesthesia in horses [15] . However, the infusion of dobutamine sometimes leads to the development of cardiac arrythmias and tachycardia [27, 30] .
On the other hand, the infusion of injectable anesthetic drug combinations during inhalation anesthesia reduces the requirement for inhalant anesthesia and helps to preserve cardiovascular function [26, 27] . Continuous infusion of guaifenesine, ketamine and medetomidine during anesthesia with sevoflurane in horses minimized cardiovascular effects by reducing the requirement for sevoflurane [27] . In that study, the end-tidal concentration of sevoflurane required to maintain a surgical plane of anesthesia in horses receiving the guaifenesin-ketamine-medetomidine infusion (1.5%) was half of that required in horses not receiving this infusion (3.0%). In clinical trial in horses, the infusion of guaifenesin, ketamine and medetomidine drug combination and inhalation of sevoflurane resulted in better transition and maintenance phases while improving cardiovascular function and reducing the number of attempts needed to stand after the completion of anesthesia, compared with inhalation of sevoflurane [26] .
Guaifenesin, a centrally acting skeletal muscle relaxant, is administered to horse in concentrations ranging from 5-15%. Unfortunately, there is no commercially available pharmaceutical preparation of guaifenesin in Japan, thus the preparation of guaifenesin-ketamine-medetomidine drug combination is troublesome in clinical practice. Brock et al. [6] reported that guaifenesin could be replaced by diazepam in horses. However, diazepam is not suitable for infusion because it has a non-water soluble property. Midazolam is a water soluble benzodiazepine that produces similar pharmacologic effects to guaifenesin and diazepam in horses [8] . Therefore, it is expected that the infusion of midazolam, ketamine and medetomidine drug combination will provide similar effects to that of guaifenesin, ketamine and medetomidine drug combination during inhalation anesthesia.
The purpose of this study was to assess the anesthetic sparring and cardiovascular effects of midazolam, ketamine and medetomidine drug combination during oxygen-sevoflurane (MKM-OS) anesthesia, preliminary to clinical application in horses.
MATERIALS AND METHODS

Evaluation of MKM-OS anesthesia:
Six clinically healthy thoroughbred horses (3 stallions, 2 geldings, 1 mare; aged 8.8 ± 5.2; 474 ± 57 kg body weight, mean ± standard deviation) were anesthetized with MKM-OS for surgical relocation of their right carotid artery to a subcutaneous position. These horses were cared for according to the principles of the 'Guide for the Care and Use of Laboratory Animals' prepared by Rakuno Gakuen University. Food, but not water, was withheld for at least 12 hr before anesthesia in all horses. The horses were administered 0.005 mg/kg of medetomidine (Domitor, Meiji Seika Co., Tokyo, Japan) intravenously (IV) through a 14-gauge catheter (Angiocath, Becton Dickinson Japan, Inc., Tokyo, Japan) placed in the left jugular vein 5 min before inducing anesthesia. Anesthesia was produced by IV administration of 2.5 mg/kg of ketamine (Ketalar, Sankyo Co., Tokyo, Japan) and 0.04 mg/kg of midazolam (Dormicum, Yamanouchi Pharmaceutical Co., Tokyo, Japan). All horses were orotrachealy intubated and connected to a large animal anesthetic circle system (LAVAC-2000, JD medical, Phoenix, AZ, U.S.A.) which delivered oxygen and sevoflurane (Sevofrane, Maruishi Pharmaceutical Co., Tokyo, Japan). The MKM (midazolam 0.8 mg/ml-ketamine 40 mg/ml-medetomidine 0.05 mg/ml, 0.025 ml/kg/hr) drug combination was infused (TE-311, Terumo, Tokyo, Japan) through the 14-gauge intravenous catheter. Surgical anesthesia was maintained by controlling the concentration of sevoflurane delivered (Sevotec 3, Ohmeda, West Yorkshire, U.K.). Breathing was controlled immediately after induction of anesthesia and continued to the end of anesthesia. All horses were ventilated by IPPV at 8 breaths/min (the ratio of expiratory time to inspiratory time was 2: 1). Peak airway pressure was adjusted to maintain an arterial carbon dioxide tension (PaCO 2 ; mmHg) between 40 and 50 mmHg. All horses were administered lactated Ringer's solution (Solulact, Terumo) IV at 10 ml/ kg/hr.
Body temperature (BT; °C), heart rate (HR; beats/min), respiratory rate (RR; breaths/min), arterial blood pressure (ABP; mmHg), the end-tidal concentration of sevoflurane (ET SEV ; %), PaCO 2 (mmHg) and arterial oxygen tension (PaO 2 ; mmHg) were determined during anesthesia in all horses. Respiratory gas was collected continuously from the oral end of the endtracheal tube, and RR and ET SEV were measured by an anesthetic gas monitor (Type 1304, Bruel & Kjar, Copenhagen, Denmark). BT, HR and ABP were determined by an anesthetic monitoring system (DS-5300, Fukuda Denshi, Tokyo, Japan). ABP was determined by connecting an 18-gauge catheter (Supercath, Medikit Co., Tokyo, Japan) which had been percutaneously placed in the right dorsal metatarsal artery to a pressure transducer (CDX-A90, Cobe Laboratories, Tokyo, Japan). The pressure transducer was positioned at the level of the sternum. Anaerobic arterial blood samples were in heparinized syringes and immediately analyzed (Rapidlab 348, Bayer Japan, Tokyo, Japan).
The infusion of MKM drug combination and inhalation of sevoflurane were discontinued at the end of the surgical procedure and the horses disconnected from the anesthetic system and transferred to a padded recovery stall. All horses were positioned in left lateral recumbency and administered oxygen enriched air. All horses recovered unassisted. Time to swallowing, first movement, sternal recumbency and standing from the cessation of MKM-OS anesthesia and the number of attempts to stand were recorded.
Cardiovascular effects of MKM-OS anesthesia:
Five healthy thoroughbred horses (3 stallions, 2 mare; aged 9.9 ± 7.0; 476 ± 37 kg body weight) were anesthetized on two occasions and positioned in left lateral (LR, n=5) or dorsal recumbency (DR, n=5), with a minimum interval of 1 month between anesthesias. The horses were restrained in wooden stocks, and an 18-gauge catheter (Supercath, Medikit Co.) was placed in the previously repositioned right carotid artery. An 8-french introducer (Exacta percutaneous sheath introducer, Ohmeda) was placed in the right jugular vein after local anesthesia. A 9-french introducer (Exacta percutaneous sheath introducer, Ohmeda) was placed in the right jugular vein 30 cm cranial to the 8-french introducer after local anesthesia. A 7-french thermodilution catheter (CritiCath SP-5107, Ohmeda) was placed in the pulmonary artery through the 8-french introducer. An 8-french catheter 100 cm in length (Intervec super guiding catheter, Fuji Systems Co., Tokyo, Japan) was placed in the right atrium through the 9-french introducer. The distance between the tip of thermodilution catheter and the 8-french catheter was adjusted to 40-50 cm.
Baseline cardiovascular data were recorded in all horses standing in stocks. ABP, pulmonary artery pressure (PAP; mmHg), and right atrial pressure (RAP; mmHg) were measured by connecting catheters placed in the raised carotid artery, the pulmonary artery and the right atrium, respectively, to pressure transducers (CDX-A90, Cobe Laboratories). Cardiac output (CO; L/min) was measured by thermodilution [17] . A volume of 40 ml of 0°C 5% dextrose was injected manually for approximately 2 sec through the 8-french catheter placed in the right atrium. Temperature fluctuation was detected using a thermodilution catheter placed in the pulmonary artery. The CO was measured three times, and the mean value of three measurements was calculated. HR, ABP, PAP, RAP and CO were recorded by a computer based data acquisition system (DS-5300, Fukuda Denshi). Cardiac index (CI; ml/min/kg) was calculated from the body weight and CO; stroke volume (SV; ml/beat) was calculated from the HR and CO; and systemic vascular resistance (SVR; dynes⋅sec⋅cm -5 ) was determined from the mean ABP (MABP), CO and the mean RAP (MRAP). CI, SV and SVR were calculated by inserting values into formulas below [5] . CI (ml/min/kg) = CO/Body Weight × 1,000 SV (ml/beat) = CO/HR SVR (dynes⋅sec⋅cm -5 ) = 60 × (MABP-MRAP) × 1,332/ CO/1,000
All horses were anesthetized for 4 hr with MKM-OS using the same anesthetic protocol, management of ventilation and fluid therapy as in horses surgically translocated their carotid artery. During anesthesia, the ET SEV in each group was maintained at the mean value that achieved surgical anesthesia for carotid artery translocation. The cardiovascular measurements were recorded every 30 min after the induction of anesthesia. The pressure transducers were placed at the level of the sternum for horses in LR or at the level of the shoulder for horses in DR. The horses were not assisted in recovery. Time to swallowing, first movement, sternal recumbency and standing from the cessation of MKM-OS anesthesia and the number of attempts to stand were recorded.
Statistical analysis: Data are reported as mean ± standard deviation. A two-way repeated measures analysis of variance was used to analyze the data. A p < 0.05 was considered significant.
RESULTS
MKM-OS anesthesia and surgery:
The induction of anesthesia was very smooth. All horses fell down without paddling between 50-90 sec after injection of midazolam and ketamine. MKM-OS anesthesia provided excellent general anesthesia for carotid artery translocation in all horses. Transition to maintenance anesthesia was also very smooth and achieved by controlling the dial setting of the vaporizer. No horse needed any additional injectable anesthetics during transition and maintenance phases. All horses were ventilated by IPPV with 14-25 cmH 2 
Cardiovascular effects of MKM-OS anesthesia: All horses inhaled sevoflurane at 1.7% of ET SEV throughout 4 hr of MKM-OS anesthesia because this concentration provided the surgical plane of anesthesia for the translocation of the carotid artery. Horses were ventilated by IPPV with 20-30 cmH 2 O of peak airway pressure to maintain the PaCO 2 levels at 40-50 mmHg, regardless of posture. The cardiorespiratory effects of MKM-OS for horses positioned in LR and DR were similar although horses in DR had a lower MABP, CO, CI and PaO 2 ( Table 2) . No horse developed a MABP of less than 70 mmHg during 4 hr of anesthesia. MPAP and MRAP were significantly lower in the group DR than the group LR (p = 0.018 and 0.022, respectively). CO and CI were maintained at approximately 70-80% of the baseline value in the group LR and 65-70% of the baseline value in the group DR, respectively. SV was maintained at approximately 75-85% of the baseline value in the group LR and 60-70% of the baseline value in the group DR, respectively. SVR was maintained at approximately 85-105% of the baseline value in the group LR and 105-125% of the baseline value in the group DR, respectively. Oxygenation was also excellent in all horses and the PaO 2 levels reached to 200-400 mmHg. There were no significant differences in the recovery variables between groups LR and DR (Table  3 ). All horses recovered from anesthesia without excitement and incident, and stood with slight ataxia remaining for 15-20 min. 
DISCUSSION
The minimum alveolar concentration (MAC) of sevoflurane is reported to be 2.31% in horses [2] . Generally, surgical anesthesia is provided with 1.2-1.4 times of MAC when using inhalation anesthesia [22] . The ET SEV providing a surgical plane of anesthesia for horses anesthetized with oxygen-sevoflurane is reported to be 3.0% (1.30 MAC) for carotid artery translocation [27] , 2.0-3.3% (0.87-1.43 MAC) for exploratory laparotomy [7] , and 2.5-2.8% (1.08-1.21 MAC) for orthopedic surgery [20] . In the present study, only 1.7% of ET SEV (0.74 MAC) provided the surgical plane of anesthesia for the carotid artery translocation. The infusion of MKM drug combination resulted in about 40% reduction in ET SEV providing a surgical plane of anesthesia for carotid artery translocation compared to a previous report [27] . Midazolam is a central acting skeletal muscule relaxant that selectively depress the transmission of impulses at the interneurons of spinal cord, brain stem and subcortical regions of the brain [1, 23] . Midazolam has been demonstrated to enhance the analgesic effects of opioids and alpha 2 -agonists [21, 24] . Ketamine, a dissociative anesthetic agent, produces analgesic effects by antagonizing Nmethyl-D-aspartate (NMDA) receptors [10, 13] . Medetomidine, an α 2 -adrenergic agonist, produces analgesia, sedation and muscle relaxation by stimulating prejunctional α 2 -receptors within the sympathetic nervous system [23] . The α 2 -adrenergic agonists contribute to analgesia activating descending adrenergic nociceptive pathways [12] . The infusion of MKM drug combination provided a potent anes- thetic effect through these mechanisms for analgesic, sedative and muscle relaxing effects. Yamashita et al. [26, 27] reported that the infusion of guaifenesin 25 mg/kg/hr, ketamine 1.0 mg/kg/hr and medetomidine 0.00125 mg/kg/hr resulted in 38% (maximum) reduction in the delivered concentration of sevoflurane in clinical cases [26] and 50% reduction in ET SEV providing a surgical plane of anesthesia for carotid artery translocation [27] in horses. The muscular relaxant effects of guaifenesin can be replaced by benzodiazepines and it has been reported that diazepam 0.1 mg/kg can be substituted for guaiafenesin 100 mg/kg and produces a comparable quality of anesthesia in horses [6] . Midazolam has been administered at dosages similar to diazepam (0.01-0.02 mg/ kg) in equine practice [16] . Based on these reports, we determined the replacement of guaifenesin 25 mg/kg/hr by midazolam 0.02 mg/kg/hr for MKM drug combination. The infusion of MKM drug combination (midazolam 0.02 mg/ kg/hr, ketamine 1.0 mg/kg/hr and medetomidine 0.00125 mg/kg/hr) provided a similar anesthetic effect to the infusion of guaifenesin, ketamine and medetomidine [26, 27] . In addition, the MKM drug combination provided clinical conveniences such as a small infusion volume (12.5 ml/hr for a horse weighing 500 kg) and easy preparation (the three drugs can be added to the same syringe).
The arterial blood pressure was well maintained during MKM-OS anesthesia. Cardiac output was also maintained good at approximately 65-70% of the baseline values in DR horses and 70-80% of the baseline values in LR horses. Systemic vascular resistance did not significantly increased in both DR and LR horses. Sevoflurane induces a dosedependent depression in hemodynamic variables in horses [3] . The reduction of sevoflurane requirement during MKM-OS anesthesia most likely minimized the cardiovascular depression and preserved cardiovascular function in horses. Furthermore, a very low infusion rate of medetomidine (0.00125 mg/kg/hr) did not cause vascular constriction attributed to increase in systemic vascular resistance. These cardiovascular effects produced by the infusion of MKM drug combination were similar to those produced by the infusion of guaifenesin-ketamine-medetomidine drug combination [27] . We concluded that the infusion of MKM drug combination produced similar anesthetic and cardiovascular effects to those produced by the infusion of guaifenesin-ketamine-medetomidine in horses.
The pronounced cardiovascular depression during anesthesia has been reported in horses positioned in dorsal recumbency [9] . Controlled mechanical ventilation also induces cardiovascular depression [9, 14] , particularly in the horses positioned in dorsal recumbency [9] . In the present study, pulmonary artery pressure and right atrial pressure were lower in DR horses. It was suggested that a decrease in preload was severer in DR horses than in LR horses. In dorsal recumbency, the compression of the caudal vena cava by abdominal organs results in the decrease in preload [9, 19] . However, cardiac output was well maintained in both LR and DR horses and we did not observe any significant difference in cardiac output between LR and DR horses. These findings suggested that MKM-OS anesthesia could preserve cardiovascular function in horses positioned in dorsal posture even with controlled ventilation.
Recovery from anesthesia is a potentially dangerous period for horses and is influenced by many factors, including individual variability, presence of hypotension during anesthesia, type of surgical procedure, duration of anesthesia, external stimuli and use of sedatives as adjunctive drugs [15] . All of the horses in the present study recovered from anesthesia without incident and stood after 1-4 attempts. Recovery from MKM-OS anesthesia was similar to previous reports using the infusion of guaifenesin-ketaminemedetomidine drug combination and sevoflurane anesthesia in horses [26, 27] . Our horses also demonstrated ataxia persisted for 15-20 min after standing. Gangle et al. [8] also reported pronounced ataxia during recovery from halothane anesthesia in horses administered midazolam (0.06 mg/kg IV) and ketamine (2.2 mg/kg IV) for induction. The halflife of midazolam in horses (approximately 2 hr [1] ) is longer than for ketamine (42 min [11] , 65.8 min [25] , or 89.9 min [18] ) or medetomidine (51.3 min [4] ). The muscle relaxation produced by midazolam may be responsible for the ataxia during recovery. Application of head and tail ropes to assist horses in their standing should be considered during the recovery phase of MKM-OS anesthesia.
In conclusion, the combination of MKM drug infusion and inhalation of sevoflurane provided the reduction of sevoflurane requirement for achieving a surgical plane of anesthesia and preservation of cardiovascular function in horses. In addition, MKM drug combination has excellent conveniences in preparation and administration for clinical practice. MKM-OS anesthesia may be useful for prolonged anesthesia and surgical procedures for horses.
